In April I wrote about vaccine development  for COVID-19.  That article outlines some of the background information you might want to read if you are not familiar with this topic.  At the time the frontrunner, the Moderna messenger ribonucleic acid (mRNA) vaccine, had been in trials for about a month.  This week the New England … Continue reading Some good news about a promising COVID-19 vaccine